X-linked agammaglobulinemia differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Vishnu Vardhan Serla (talk | contribs)
Created page with "__NOTOC__ {{X-linked agammaglobulinemia}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==Reference..."
 
Vishnu Vardhan Serla (talk | contribs)
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{X-linked agammaglobulinemia}}
{{X-linked agammaglobulinemia}}
Please help WikiDoc by adding content here. It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
{{CMG}}
==Overview==
== Differential Diagnosis ==
Agammaglobulinemia (XLA) is similar to the primary immunodeficiency disorder Hypogammaglobulinemia (CVID), and their clinical conditions and treatment are almost identical. However, while XLA is a congenital disorder, with known genetic causes, CVID may occur in adulthood and its causes are not yet understood.
 
XLA was also historically mistaken as Severe Combined Immunodeficiency (SCID), a much more severe immune deficiency ("Bubble boys").  
 
A strain of laboratory mouse, XID, is used to study XLA. These mice have a mutated version of the mouse Btk gene, and exhibit a similar, yet milder, immune deficiency as in XLA.
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 17:52, 21 September 2012

X-linked agammaglobulinemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating X-linked agammaglobulinemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Serology

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

X-linked agammaglobulinemia differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of X-linked agammaglobulinemia differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on X-linked agammaglobulinemia differential diagnosis

CDC on X-linked agammaglobulinemia differential diagnosis

X-linked agammaglobulinemia differential diagnosis in the news

Blogs on X-linked agammaglobulinemia differential diagnosis

Directions to Hospitals Treating X-linked agammaglobulinemia

Risk calculators and risk factors for X-linked agammaglobulinemia differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Differential Diagnosis

Agammaglobulinemia (XLA) is similar to the primary immunodeficiency disorder Hypogammaglobulinemia (CVID), and their clinical conditions and treatment are almost identical. However, while XLA is a congenital disorder, with known genetic causes, CVID may occur in adulthood and its causes are not yet understood.

XLA was also historically mistaken as Severe Combined Immunodeficiency (SCID), a much more severe immune deficiency ("Bubble boys").

A strain of laboratory mouse, XID, is used to study XLA. These mice have a mutated version of the mouse Btk gene, and exhibit a similar, yet milder, immune deficiency as in XLA.

References

Template:WH Template:WS